Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

ACR Appropriateness Criteria® Gestational Trophoblastic Disease.

Expert Panel on Women’s Imaging Panel, Dudiak KM, Maturen KE, Akin EA, Bell M, Bhosale PR, Kang SK, Kilcoyne A, Lakhman Y, Nicola R, Pandharipande PV, Paspulati R, Reinhold C, Ricci S, Shinagare AB, Vargas HA, Whitcomb BP, Glanc P.

J Am Coll Radiol. 2019 Nov;16(11S):S348-S363. doi: 10.1016/j.jacr.2019.05.015.

PMID:
31685103
2.

Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer.

Cybulska P, Hayes SA, Spirtos A, Rafizadeh MJ, Filippova OT, Leitao M, Zivanovic O, Sonoda Y, Mueller J, Lakhman Y, Long K, Chi DS.

Int J Gynecol Cancer. 2019 Nov;29(9):1377-1380. doi: 10.1136/ijgc-2019-000829. Epub 2019 Oct 1.

PMID:
31575614
3.

Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?

Himoto Y, Cybulska P, Shitano F, Sala E, Zheng J, Capanu M, Nougaret S, Nikolovski I, Vargas HA, Wang W, Mueller JJ, Chi DS, Lakhman Y.

Gynecol Oncol. 2019 Nov;155(2):192-200. doi: 10.1016/j.ygyno.2019.08.011. Epub 2019 Sep 12.

PMID:
31521322
4.

Polypoid endometriosis: a mimic of malignancy.

Ghafoor S, Lakhman Y, Park KJ, Petkovska I.

Abdom Radiol (NY). 2019 Aug 1. doi: 10.1007/s00261-019-02143-8. [Epub ahead of print]

PMID:
31372776
5.

Malignant Diseases of the Uterus.

Lakhman Y, Reinhold C.

In: Hodler J, Kubik-Huch RA, von Schulthess GK, editors. Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book [Internet]. Cham (CH): Springer; 2018. Chapter 18.
2018 Mar 21.

6.

MRI of Tumors and Tumor Mimics in the Female Pelvis: Anatomic Pelvic Space-based Approach.

Nougaret S, Nikolovski I, Paroder V, Vargas HA, Sala E, Carrere S, Tetreau R, Hoeffel C, Forstner R, Lakhman Y.

Radiographics. 2019 Jul-Aug;39(4):1205-1229. doi: 10.1148/rg.2019180173.

7.

ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms.

Expert Panel on Women’s Imaging:, Atri M, Alabousi A, Reinhold C, Akin EA, Benson CB, Bhosale PR, Kang SK, Lakhman Y, Nicola R, Pandharipande PV, Patel MD, Salazar GM, Shipp TD, Simpson L, Sussman BL, Uyeda JW, Wall DJ, Whitcomb BP, Zelop CM, Glanc P.

J Am Coll Radiol. 2019 May;16(5S):S77-S93. doi: 10.1016/j.jacr.2019.02.011.

PMID:
31054761
8.

Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease.

Kumar A, Sheedy S, Kim B, Suidan R, Sarasohn DM, Nikolovski I, Lakhman Y, McGree ME, Weaver AL, Chi D, Cliby WA.

Gynecol Oncol. 2019 Jul;154(1):72-76. doi: 10.1016/j.ygyno.2019.04.011. Epub 2019 Apr 16.

PMID:
31000471
9.

Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer.

Meier A, Veeraraghavan H, Nougaret S, Lakhman Y, Sosa R, Soslow RA, Sutton EJ, Hricak H, Sala E, Vargas HA.

Abdom Radiol (NY). 2019 Jun;44(6):2040-2047. doi: 10.1007/s00261-018-1840-5.

PMID:
30474722
10.

Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology.

Nougaret S, Horta M, Sala E, Lakhman Y, Thomassin-Naggara I, Kido A, Masselli G, Bharwani N, Sadowski E, Ertmer A, Otero-Garcia M, Kubik-Huch RA, Cunha TM, Rockall A, Forstner R.

Eur Radiol. 2019 Feb;29(2):792-805. doi: 10.1007/s00330-018-5515-y. Epub 2018 Jul 11. Review.

PMID:
29995239
11.

ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer.

Expert Panel on Women’s Imaging:, Kang SK, Reinhold C, Atri M, Benson CB, Bhosale PR, Jhingran A, Lakhman Y, Maturen KE, Nicola R, Pandharipande PV, Salazar GM, Shipp TD, Simpson L, Small W Jr, Sussman BL, Uyeda JW, Wall DJ, Whitcomb BP, Zelop CM, Glanc P.

J Am Coll Radiol. 2018 May;15(5S):S198-S207. doi: 10.1016/j.jacr.2018.03.015.

PMID:
29724422
12.

CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.

Nougaret S, Lakhman Y, Molinari N, Feier D, Scelzo C, Vargas HA, Sosa RE, Hricak H, Soslow RA, Grisham RN, Sala E.

AJR Am J Roentgenol. 2018 Apr;210(4):918-926. doi: 10.2214/AJR.17.18254. Epub 2018 Feb 28.

13.

Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

McEvoy SH, Nougaret S, Abu-Rustum NR, Vargas HA, Sadowski EA, Menias CO, Shitano F, Fujii S, Sosa RE, Escalon JG, Sala E, Lakhman Y.

Abdom Radiol (NY). 2017 Dec;42(12):2966-2973. doi: 10.1007/s00261-017-1205-5.

PMID:
29128990
14.

ACR Appropriateness Criteria® Ovarian Cancer Screening.

Expert Panel on Women’s Imaging:, Pandharipande PV, Lowry KP, Reinhold C, Atri M, Benson CB, Bhosale PR, Green ED, Kang SK, Lakhman Y, Maturen KE, Nicola R, Salazar GM, Shipp TD, Simpson L, Sussman BL, Uyeda J, Wall DJ, Whitcomb B, Zelop CM, Glanc P.

J Am Coll Radiol. 2017 Nov;14(11S):S490-S499. doi: 10.1016/j.jacr.2017.08.049.

PMID:
29101987
15.

Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer.

Chan AT, Plodkowski AJ, Pun SC, Lakhman Y, Halpenny DF, Kim J, Goldburg SR, Matasar MJ, Moskowitz CS, Gupta D, Steingart R, Weinsaft JW.

J Cardiovasc Magn Reson. 2017 Oct 12;19(1):76. doi: 10.1186/s12968-017-0390-2.

16.

From Staging to Prognostication: Achievements and Challenges of MR Imaging in the Assessment of Endometrial Cancer.

Nougaret S, Lakhman Y, Vargas HA, Colombo PE, Fujii S, Reinhold C, Sala E.

Magn Reson Imaging Clin N Am. 2017 Aug;25(3):611-633. doi: 10.1016/j.mric.2017.03.010. Epub 2017 May 27. Review.

PMID:
28668163
17.

Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

Vargas HA, Huang EP, Lakhman Y, Ippolito JE, Bhosale P, Mellnick V, Shinagare AB, Anello M, Kirby J, Fevrier-Sullivan B, Freymann J, Jaffe CC, Sala E.

Radiology. 2017 Nov;285(2):482-492. doi: 10.1148/radiol.2017161870. Epub 2017 Jun 22.

18.

High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

Nougaret S, Lakhman Y, Gönen M, Goldman DA, Miccò M, D'Anastasi M, Johnson SA, Juluru K, Arnold AG, Sosa RE, Soslow RA, Vargas HA, Hricak H, Kauff ND, Sala E.

Radiology. 2017 Nov;285(2):472-481. doi: 10.1148/radiol.2017161697. Epub 2017 Jun 16.

19.

Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

McEvoy SH, Nougaret S, Abu-Rustum NR, Vargas HA, Sadowski EA, Menias CO, Shitano F, Fujii S, Sosa RE, Escalon JG, Sala E, Lakhman Y.

Abdom Radiol (NY). 2017 Oct;42(10):2488-2512. doi: 10.1007/s00261-017-1179-3. Review. Erratum in: Abdom Radiol (NY). 2017 Nov 11;:.

20.

A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.

Vargas HA, Veeraraghavan H, Micco M, Nougaret S, Lakhman Y, Meier AA, Sosa R, Soslow RA, Levine DA, Weigelt B, Aghajanian C, Hricak H, Deasy J, Snyder A, Sala E.

Eur Radiol. 2017 Sep;27(9):3991-4001. doi: 10.1007/s00330-017-4779-y. Epub 2017 Mar 13.

21.

Abdominal wall endometriosis: differentiation from other masses using CT features.

Yarmish G, Sala E, Goldman DA, Lakhman Y, Soslow RA, Hricak H, Gardner GJ, Vargas HA.

Abdom Radiol (NY). 2017 May;42(5):1517-1523. doi: 10.1007/s00261-016-0998-y.

22.

Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.

Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, Nougaret S, Sosa RE, Vargas HA, Soslow RA, Abu-Rustum NR, Hricak H, Sala E.

Eur Radiol. 2017 Jul;27(7):2903-2915. doi: 10.1007/s00330-016-4623-9. Epub 2016 Dec 5.

23.

Response.

Nougaret S, Reinhold C, Lakhman Y, Guiu B, Sala E.

Radiology. 2016 Apr;279(1):326-7. No abstract available.

PMID:
27437554
24.

A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma.

Carlo MI, Molina AM, Lakhman Y, Patil S, Woo K, DeLuca J, Lee CH, Hsieh JJ, Feldman DR, Motzer RJ, Voss MH.

Oncologist. 2016 Jul;21(7):787-8. doi: 10.1634/theoncologist.2016-0145. Epub 2016 Jun 10.

25.

Pattern and Prognostic Implications of Cardiac Metastases Among Patients With Advanced Systemic Cancer Assessed With Cardiac Magnetic Resonance Imaging.

Pun SC, Plodkowski A, Matasar MJ, Lakhman Y, Halpenny DF, Gupta D, Moskowitz C, Kim J, Steingart R, Weinsaft JW.

J Am Heart Assoc. 2016 May 4;5(5). pii: e003368. doi: 10.1161/JAHA.116.003368.

26.

The Wheel of the Mesentery: Imaging Spectrum of Primary and Secondary Mesenteric Neoplasms--How Can Radiologists Help Plan Treatment?: Resident and Fellow Education Feature.

Nougaret S, Lakhman Y, Reinhold C, Addley HC, Fujii S, Delhom E, Guiu B, Sala E.

Radiographics. 2016 Mar-Apr;36(2):412-3. doi: 10.1148/rg.2016150186. No abstract available.

27.

Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

Nougaret S, Vargas HA, Lakhman Y, Sudre R, Do RK, Bibeau F, Azria D, Assenat E, Molinari N, Pierredon MA, Rouanet P, Guiu B.

Radiology. 2016 Aug;280(2):446-54. doi: 10.1148/radiol.2016150702. Epub 2016 Feb 26.

28.

Imaging Features of Uncommon Gynecologic Cancers.

Miccò M, Sala E, Lakhman Y, Hricak H, Vargas HA.

AJR Am J Roentgenol. 2015 Dec;205(6):1346-59. doi: 10.2214/AJR.14.12695. Review.

29.

Is It Time to Centralize Ovarian Cancer Care in the United States?

Cowan RA, O'Cearbhaill RE, Gardner GJ, Levine DA, Roche KL, Sonoda Y, Zivanovic O, Tew WP, Sala E, Lakhman Y, Vargas Alvarez HA, Sarasohn DM, Mironov S, Abu-Rustum NR, Chi DS.

Ann Surg Oncol. 2016 Mar;23(3):989-93. doi: 10.1245/s10434-015-4938-9. Epub 2015 Oct 28. Review.

30.

Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub-Specialized Radiologists Influence Patient Care.

Lakhman Y, D'Anastasi M, Miccò M, Scelzo C, Vargas HA, Nougaret S, Sosa RE, Chi DS, Abu-Rustum NR, Hricak H, Sala E.

Eur Radiol. 2016 Jul;26(7):2089-98. doi: 10.1007/s00330-015-4040-5. Epub 2015 Oct 22.

31.

Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

Lakhman Y, Nougaret S, Miccò M, Scelzo C, Vargas HA, Sosa RE, Sutton EJ, Chi DS, Hricak H, Sala E.

Radiographics. 2015 Jul-Aug;35(4):1295-313. doi: 10.1148/rg.2015140313. Review.

32.

Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus.

Lakhman Y, Katz SS, Goldman DA, Yakar D, Vargas HA, Sosa RE, Miccò M, Soslow RA, Hricak H, Abu-Rustum NR, Sala E.

Ann Surg Oncol. 2016 Apr;23(4):1271-8. doi: 10.1245/s10434-015-4410-x. Epub 2015 Feb 10.

33.

Does gadolinium-based contrast material improve diagnostic accuracy of local invasion in rectal cancer MRI? A multireader study.

Gollub MJ, Lakhman Y, McGinty K, Weiser MR, Sohn M, Zheng J, Shia J.

AJR Am J Roentgenol. 2015 Feb;204(2):W160-7. doi: 10.2214/AJR.14.12599.

34.

Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.

Lakhman Y, Yakar D, Goldman DA, Katz SS, Vargas HA, Miccò M, Zheng J, Moskowitz CS, Soslow RA, Hricak H, Abu-Rustum NR, Sala E.

Abdom Imaging. 2015 Aug;40(6):1761-8. doi: 10.1007/s00261-014-0337-0.

35.

Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes.

Di Paolo PL, Vargas HA, Karlo CA, Lakhman Y, Zheng J, Moskowitz CS, Al-Ahmadie HA, Sala E, Bochner BH, Hricak H.

Clin Imaging. 2015 Jan-Feb;39(1):94-8. doi: 10.1016/j.clinimag.2014.10.004. Epub 2014 Oct 16.

36.

Role of imaging in the pretreatment evaluation of common gynecological cancers.

Miccò M, Sala E, Lakhman Y, Hricak H, Vargas HA.

Womens Health (Lond). 2014 May;10(3):299-321. doi: 10.2217/whe.14.19.

PMID:
24956296
37.

Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration.

Vargas HA, Burger IA, Donati OF, Andikyan V, Lakhman Y, Goldman DA, Schöder H, Chi DS, Sala E, Hricak H.

Int J Gynecol Cancer. 2013 Oct;23(8):1512-9. doi: 10.1097/IGC.0b013e3182a41e61.

PMID:
24257566
38.

Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy.

Lakhman Y, Akin O, Park KJ, Sarasohn DM, Zheng J, Goldman DA, Sohn MJ, Moskowitz CS, Sonoda Y, Hricak H, Abu-Rustum NR.

Radiology. 2013 Oct;269(1):149-58. doi: 10.1148/radiol.13121746. Epub 2013 Jun 20.

39.

Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.

Donati OF, Lakhman Y, Sala E, Burger IA, Vargas HA, Goldman DA, Andikyan V, Park KJ, Chi DS, Hricak H.

Eur Radiol. 2013 Oct;23(10):2906-15. doi: 10.1007/s00330-013-2875-1. Epub 2013 May 8.

PMID:
23652852
40.

Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes.

Vargas HA, Chaim J, Lefkowitz RA, Lakhman Y, Zheng J, Moskowitz CS, Sohn MJ, Schwartz LH, Russo P, Akin O.

Radiology. 2012 Sep;264(3):779-88. doi: 10.1148/radiol.12110746. Epub 2012 Jul 24.

PMID:
22829683
41.

Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.

Lakhman Y, Akin O, Sohn MJ, Zheng J, Moskowitz CS, Iyer RB, Barakat RR, Sabbatini PJ, Chi DS, Hricak H.

AJR Am J Roentgenol. 2012 Jun;198(6):1453-9. doi: 10.2214/AJR.11.7257.

PMID:
22623562
42.

Dilated cisternae chyli: a sign of uncompensated cirrhosis at MR imaging.

Verma SK, Mitchell DG, Bergin D, Lakhman Y, Austin A, Verma M, Assis D, Herrine SK, Parker L.

Abdom Imaging. 2009 Mar-Apr;34(2):211-6. doi: 10.1007/s00261-008-9369-7.

PMID:
18219518
43.

Paraumbilical collateral veins on MRI as possible protection against portal venous thrombosis in candidates for liver transplantation.

Verma SK, Mitchell DG, Lakhman Y, Bergin D, Dolin RJ, Doria C, Parker L.

Abdom Imaging. 2008 Sep-Oct;33(5):536-41.

PMID:
17924159

Supplemental Content

Loading ...
Support Center